Community Practice Grand Rounds: Experts Explore the Latest Evidence and Guideline Updates in Chronic Lymphocytic Leukemia

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
Community Practice Grand Rounds: Experts Explore the Latest Evidence and Guideline Updates in Chronic Lymphocytic Leukemia

Content Format:

Slideset

Credit Type:

--

Credits:

--
Answering Key Questions in the Optimal Treatment for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
Répondre aux questions clés concernant le traitement optimal des patients atteints de leucémie lymphoïde chronique récurrente ou réfractaire

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Risposte alle domande chiave sul trattamento ottimale per i pazienti con leucemia linfatica cronica recidivata/refrattaria

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Respondendo a perguntas-chave sobre o tratamento ideal para doentes com leucemia linfocítica crónica recaída/refratária

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Responder a las preguntas clave en el tratamiento óptimo de los pacientes con leucemia linfocítica crónica recidivante/refractaria

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Beantwortung wichtiger Fragen zur optimalen Behandlung von Patientinnen und Patienten mit rezidivierter/refraktärer chronischer lymphatischer Leukämie

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL for Physicians

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: A Global Perspective

Content Format:

Credits Only

Credit Type:

AMA | EBAC®

Credits:

1.50
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: A Global Perspective

Content Format:

Slideset

Credit Type:

AMA

Credits:

1.00
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Frontline Treatment

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Frontline Treatment

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Interactive Tool for Managing Adverse Events Associated With BCL-2 Inhibitors in Hematologic Malignancies

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL

Content Format:

Tool

Credit Type:

--

Credits:

--
Current Clinical Practice and NCCN Guidelines for CLL/SLL

Content Format:

Podcast Episodes

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Aligning Current Clinical Practice With NCCN CLL/SLL Guidelines

Content Format:

Slideset

Credit Type:

--

Credits:

--
Relapsed/Refractory CLL/SLL and MCL: Training and Resources to Optimize Outcomes

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Call to Action: Addressing Barriers to Optimal Management of Patients With Relapsed/Refractory CLL and MCL Using Innovative Therapies

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
FAQs: Fine-tuning Contemporary Treatment for Patients With CLL/SLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Management of Patients with Newly Diagnosed CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL

Content Format:

Tool

Credit Type:

--

Credits:

--